Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% |
|
-.--% | -.--% |
2020 | PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc.. | CI |
2020 | PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc.. | CI |
Financials (USD)
Sales 2011 | 88.83M | Sales 2012 | 94.55M | Capitalization | 9.63M |
---|---|---|---|---|---|
Net income 2011 | 13M | Net income 2012 | 17M | EV / Sales 2011 | 0.24 x |
Net cash position 2011 | 14.72M | Net cash position 2012 | 26.92M | EV / Sales 2012 | -0.18 x |
P/E ratio 2011 |
2.66
x | P/E ratio 2012 |
0.55
x | Employees | 171 |
Yield 2011 * |
-
| Yield 2012 |
-
| Free-Float | 98.86% |
![Extreme 0](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.54K | |
+54.07% | 809B | |
+38.59% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+13.40% | 238B | |
+0.61% | 221B | |
+13.24% | 218B | |
+7.42% | 166B |
- Stock Market
- Equities
- KALY Stock